What is Hexarelin?

Hexarelin is a research peptide in the GH Secretagogue class. Potent ghrelin-receptor agonist; strong acute GH release. It is studied at per-dose ranges of 100 mcg × 2–3 / day (2–4 mg weekly), administered 2–3× daily sc over cycles of 4–8 weeks. Supplied in Thailand by Thailand Peptides — Bangkok-based, research use only.

Hexapeptide GHS. Stronger acute GH-release profile than ipamorelin but with greater cortisol/prolactin impact.

Published and preclinical data are summarised below; dose ranges shown reflect protocols in the research literature and should be interpreted accordingly.

How does Hexarelin work?

Primary mechanism: Potent ghrelin-receptor agonist; strong acute GH release. Research on Hexarelin implicates downstream effects on related signalling cascades, with magnitude and clinical relevance dependent on dose, timing, and individual pharmacogenomic factors.

Receptor binding affinity and post-receptor signalling for Hexarelin remain areas of active investigation; several proposed effects within the GH Secretagogue class are currently supported only by in-vitro or rodent data, and should be interpreted accordingly.

Hexarelin dosage & protocol

Reference protocol for Hexarelin (research context only, drawn from published literature):

  • Per dose: 100 mcg × 2–3 / day
  • Weekly total: 2–4 mg
  • Frequency: 2–3× daily SC
  • Cycle: 4–8 weeks

Stacking Hexarelin

Commonly referenced pairing with Hexarelin: GHRH analog. Stacking rationale should be grounded in complementary mechanisms, not additive speculation; interactions at shared receptors or enzymatic pathways should be accounted for. Both compounds in a Hexarelin stack are supplied by Thailand Peptides on the same order via the Bangkok research desk.

Contraindications

Active malignancy. Additional caution is warranted in individuals with hepatic or renal impairment, endocrine disorders, or concurrent pharmacotherapy affecting the pathways described above.

Hexarelin — common questions

What is Hexarelin and what is it used for in research?
Hexarelin is classified within the GH Secretagogue group. Hexapeptide GHS. Stronger acute GH-release profile than ipamorelin but with greater cortisol/prolactin impact. Research applications focus on the pathways outlined below. All references on this page describe published research only — Hexarelin is supplied for in-vitro and laboratory use, not for human consumption.
How does Hexarelin work?
Primary mechanism: Potent ghrelin-receptor agonist; strong acute GH release. Downstream effects depend on dose, timing, and the biological system under investigation. Receptor binding and post-receptor signalling for Hexarelin remain areas of active study, and several proposed effects are supported only by preclinical data.
What is the typical Hexarelin research dose?
Published research protocols for Hexarelin describe per-dose ranges of 100 mcg × 2–3 / day, with a weekly total near 2–4 mg, administered 2–3× daily sc. Typical cycle: 4–8 weeks. These ranges reflect the literature and are not dosing recommendations for any individual.
Where can I buy Hexarelin in Thailand?
Hexarelin is supplied by Thailand Peptides, a Bangkok-based research-peptide supplier. Orders are placed directly via WhatsApp to the Bangkok research desk — no cart, no account, no forms. Pricing and shipping are provided on request. Open a line with the research desk →
How fast can Hexarelin be delivered in Thailand?
Same-week delivery across Thailand is standard for orders confirmed within business hours (GMT+7, Monday–Saturday). Bangkok metro deliveries typically arrive within 1–3 business days; other provinces within 3–5. Regional Southeast Asia shipping is available on request.

Citations

  1. Ghigo E, et al. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide. J Clin Endocrinol Metab. 1994. PMID: 8126144
  2. Arvat E, et al. Arginine and growth hormone-releasing hormone restore the blunted GH-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab. 1994. PMID: 7962341

References curated from PubMed. Additional literature summarised in the Thailand Peptides research library.